Texas Permanent School Fund Biolife Solutions Inc Transaction History

Texas Permanent School Fund

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$15.14 - $22.99 $41,089 - $62,394	2,714 Added 8.71%	33,859 $725,000
Q1 2024 May 03, 2024	BUY	$15.35 - $18.82 $21,244 - $26,046	1,384 Added 4.65%	31,145 $577,000
Q4 2023 Feb 08, 2024	BUY	$8.99 - $16.86 $8,010 - $15,022	891 Added 3.09%	29,761 $483,000
Q3 2023 Nov 09, 2023	SELL	$10.81 - $22.96 $18,809 - $39,950	-1,740 Reduced 5.68%	28,870 $398,000
Q2 2023 Aug 07, 2023	SELL	$17.19 - $24.34 $1,237 - $1,752	-72 Reduced 0.23%	30,610 $676,000
Q1 2023 May 01, 2023	BUY	$17.67 - $26.07 $137,454 - $202,798	7,779 Added 33.96%	30,682 $667,000
Q4 2022 Feb 07, 2023	SELL	$16.95 - $25.07 $25,526 - $37,755	-1,506 Reduced 6.17%	22,903 $417,000
Q3 2022 Oct 25, 2022	BUY	$14.64 - $26.7 $36,717 - $66,963	2,508 Added 11.45%	24,409 $555,000
Q2 2022 Aug 08, 2022	BUY	$10.54 - $24.2 $6,766 - $15,536	642 Added 3.02%	21,901 $302,000
Q1 2022 May 06, 2022	BUY	$20.81 - $37.29 $2,726 - $4,884	131 Added 0.62%	21,259 $483,000
Q4 2021 Feb 08, 2022	SELL	$32.99 - $58.55 $12,668 - $22,483	-384 Reduced 1.79%	21,128 $787,000
Q3 2021 Oct 28, 2021	BUY	$42.03 - $60.5 $904,149 - $1.3 Million	21,512 New	21,512 $910,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

Stay updated on Texas Permanent School Fund with notifications on news.